Neonatal jaundice, animal-induced injuries, and immunizations

Current Opinion in Pediatrics

Volumn 13, Issue 4, 2001, Pages 377-385

  Sandora, Thomas J ^a   Bernstein, Henry H ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; RABIES VACCINE;

ADOLESCENT; BITE; CAT SCRATCH DISEASE; CHILD; EVIDENCE BASED MEDICINE; HUMAN; IMMUNIZATION; INFANT; INFECTION; MENINGOCOCCOSIS; NEWBORN; NEWBORN JAUNDICE; PRIORITY JOURNAL; PROPHYLAXIS; RABIES; REVIEW; STREPTOCOCCUS INFECTION; TOXOPLASMOSIS;

ANIMALS; ANIMALS, DOMESTIC; BITES AND STINGS; CATS; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; DISEASE RESERVOIRS; DOGS; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; JAUNDICE, NEONATAL;

EID: 0034917244     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200108000-00016     Document Type: Review

References (39)

1. Length of stay, jaundice, and hospital readmission
2. Loss of concern about jaundice and the reemergence of kernicterus in full term infants in the era of managed care
3. Hospital stay for healthy term newborns
4. Early newborn hospital discharge and readmission for mild and severe jaundice
5. Problems associated with early discharge of newborn infants. Early discharge of newborns and mothers: A critical review of the literature
6. Accuracy of clinical judgment in neonatal jaundice
7. Practice parameter: Management of hyperbilirubinemia in the healthy term newborn
8. Rebound bilirubin levels in infants receiving phototherapy
9. Pet-, animal-, and vector-borne infections
10. Human rabies - California, Georgia, Minnesota, New York, and Wisconsin, 2000
11. Human rabies prevention - United States, 1999 Recommendations of the Advisory Committee on Immunization Practices (ACIP)
12. Current concepts on animal bites: Bacteriology and therapy
13. Treating mammalian bite wounds
14. Primary closure of mammalian bites
15. National, state, and urban area vaccination coverage levels among children aged 19-35 months-United States, 1998
16. Technical report: Prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis
17. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
18. Immunogenicity of pneumococcal conjugate vaccines
19. Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis
20. Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: Herd immunity and reduction of otitis morbidity
21. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children
22. Vaccines for prevention of meningococcal disease
23. Preventing meningococcal infection in college students
24. A view from the media on vaccine safety
25. Vaccine adverse events in the new millennium: Is there reason for concern?
26. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children
27. Real or perceived adverse effects of vaccines and the media - A tale of our times
28. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association
29. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association
30. The future of research into rotavirus vaccine
31. Immunization safety: A global priority
32. Developing a national system for dealing with adverse events following immunization
33. New combination vaccines
34. Physician and parent opinions: Are children becoming pincushions from immunizations?
35. Combination vaccines: Problems and promise